세계의 청각 기기 시장 - 규모, 점유율, 동향 분석 보고서 : 기술별, 연령층별, 제품별, 판매 채널별, 부문 예측(2025-2030년)

Audiology Devices Market Growth & Trends:

The global audiology devices market size is expected to reach USD 21.13 billion in 2030 and is projected to grow at a CAGR of 6.24% from 2025 to 2030. Increasing cases of hearing disorders, especially in the geriatric population, rising purchasing capacity, investments in R&D, and strong government support for better healthcare infrastructure are expected to drive the industry growth over the forecast period. High comfort offered by newly introduced hearing aids, improved connectivity, and a better user interface is some of the factors attributing to the high usage rate of audiology devices. Better quality of life along with acceptance of digital hearing aids is anticipated to further drive the demand. In a study published in January 2019, it was observed that hearing aids reduce symptoms associated with dementia.

However, the usage is hampered due to the exclusion of fitting of hearing aids or exams from the Original Medicare program. In addition, the rising government initiatives for audiology devices are expected to propel growth. For instance, in 2019, the Government of France introduced a reform in the health system and granted 100% reimbursement for auditive, dental, and optical care with the '100 % Sante slogan. Furthermore, the prices of the hearing aids have been capped and the amount would be reimbursed by the social security system. The COVID-19 pandemic adversely affected the industry due to the supply chain disruptions, postponement of cochlear & BAHA surgeries, and decline in audiological care appointments. As per the Hearing Industries Association (HIA), the sales of hearing aids decline by 18.0% in 2020. As a result, many manufacturers reported a decline in their sales.

Audiology Devices Market Report Highlights:

• Government initiatives designed to raise awareness about hearing screenings among infants and older adults are fostering industry growth.
• The hearing aids segment led the market with the largest revenue share of 57.59% in 2024 and is expected to witness the fastest CAGR during the forecast period, owing to the significant demand for invisible-in-canal hearing aids and complete-in-canal hearing aids.
• Based on technology, the digital segment led the market with the largest revenue share of 92.96% in 2024
• Based on sales channel, the retail sales segment accounted for the largest market revenue share in 2024
• Based on age group, the adult segment accounted for the largest market revenue share in 2024

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Technology
  • 1.2.3. Sales channel
  • 1.2.4. Age Group
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing geriatric population
    • 3.2.1.2. High prevalence of hearing loss
    • 3.2.1.3. Technological advancements in Audiology devices
    • 3.2.1.4. Favorable reimbursement Policies supporting hearing aid adoption
    • 3.2.1.5. Strategic initiatives undertaken by key players
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of reimbursement and underdeveloped regulatory framework in low- & middle-income countries (LMICS)
    • 3.2.2.2. High maintenance cost
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
• 3.4. Tech innovations and M&A trends
• 3.5. Increasing prevalence of hearing loss by age and in low-, middle-, and high-income countries.
• 3.6. Projected increase in prevalence of moderate and higher grade of hearing loss, 2019 - 2050
• 3.7. People in need but not using hearing aid by low moderate- & high-income countries
• 3.8. Numbers and percentages of people in need but not using hearing aids among WHO regions

Chapter 4. Product Business Analysis

• 4.1. Product Market Share, 2024 & 2030
• 4.2. Product Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Hearing Aids
  • 4.4.1. Hearing aids market, 2018 - 2030 (USD Million)
• 4.5. Cochlear Implants
  • 4.5.1. Cochlear implants market, 2018 - 2030 (USD Million)
• 4.6. BAHA/BAHS
  • 4.6.1. BAHA/BAHS market, 2018 - 2030 (USD Million)
• 4.7. Diagnostic Devices
  • 4.7.1. Diagnostic Devices market, 2018 - 2030 (USD Million)
• 4.8. Surgical Devices
  • 4.8.1. Surgical Devices market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

• 5.1. Technology Market Share, 2024 & 2030
• 5.2. Technology Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
• 5.4. Digital Audiology Devices
  • 5.4.1. Digital audiology devices market, 2018 - 2030 (USD Million)
• 5.5. Analog Audiology Devices
  • 5.5.1. Analog audiology devices market, 2018 - 2030 (USD Million)

Chapter 6. Sales Channel Business Analysis

• 6.1. Sales Channel Market Share, 2024 & 2030
• 6.2. Sales Channel Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by Sales Channel, 2018 to 2030 (USD Million)
• 6.4. Retail Sales
  • 6.4.1. Retail sales market, 2018 - 2030 (USD Million)
• 6.5. E-commerce
  • 6.5.1. E-commerce market, 2018 - 2030 (USD Million)
• 6.6. Government Purchases
  • 6.6.1. Government purchases market, 2018 - 2030 (USD Million)

Chapter 7. Age Group Business Analysis

• 7.1. Age Group Market Share, 2024 & 2030
• 7.2. Age Group Segment Dashboard
• 7.3. Market Size & Forecasts and Trend Analysis, by Age Group, 2018 to 2030 (USD Million)
• 7.4. Adults
  • 7.4.1. Adults market, 2018 - 2030 (USD Million)
• 7.5. Pediatrics
  • 7.5.1. Pediatrics market, 2018 - 2030 (USD Million)

Chapter 8. Regional Estimates & Trend Analysis by Product, Technology, Sales Channel, and Age Group

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.4. North America
  • 8.4.1. North America audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key country dynamic
    • 8.4.2.2. U.S. estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. Reimbursement scenario
    • 8.4.2.5. Competitive insights
    • 8.4.2.6. U.S. audiology devices audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key country dynamic
    • 8.4.3.2. Canada estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. Reimbursement scenario
    • 8.4.3.5. Competitive insights
    • 8.4.3.6. Canada audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key country dynamic
    • 8.4.4.2. Mexico estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.4.4.3. Regulatory framework
    • 8.4.4.4. Reimbursement scenario
    • 8.4.4.5. Competitive insights
    • 8.4.4.6. Mexico audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key country dynamic
    • 8.5.2.2. UK estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. Competitive insights
    • 8.5.2.6. UK audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key country dynamic
    • 8.5.3.2. Germany estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. Competitive insights
    • 8.5.3.6. Germany audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key country dynamic
    • 8.5.4.2. France estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. Competitive insights
    • 8.5.4.6. France audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key country dynamic
    • 8.5.5.2. Italy estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. Reimbursement scenario
    • 8.5.5.5. Competitive insights
    • 8.5.5.6. Italy audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key country dynamic
    • 8.5.6.2. Spain estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.5.6.3. Regulatory framework
    • 8.5.6.4. Reimbursement scenario
    • 8.5.6.5. Competitive insights
    • 8.5.6.6. Spain audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Norway
    • 8.5.7.1. Key country dynamic
    • 8.5.7.2. Norway estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.5.7.3. Regulatory framework
    • 8.5.7.4. Reimbursement scenario
    • 8.5.7.5. Competitive insights
    • 8.5.7.6. Norway audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Denmark
    • 8.5.8.1. Key country dynamic
    • 8.5.8.2. Denmark estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.5.8.3. Regulatory framework
    • 8.5.8.4. Reimbursement scenario
    • 8.5.8.5. Competitive insights
    • 8.5.8.6. Denmark audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Sweden
    • 8.5.9.1. Key country dynamic
    • 8.5.9.2. Sweden estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.5.9.3. Regulatory framework
    • 8.5.9.4. Reimbursement scenario
    • 8.5.9.5. Competitive insights
    • 8.5.9.6. Sweden audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key country dynamic
    • 8.6.2.2. Japan estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. Competitive insights
    • 8.6.2.6. Japan audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key country dynamic
    • 8.6.3.2. China estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. Reimbursement scenario
    • 8.6.3.5. Competitive insights
    • 8.6.3.6. China audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key country dynamic
    • 8.6.4.2. India estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. Reimbursement scenario
    • 8.6.4.5. Competitive insights
    • 8.6.4.6. India audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. South Korea
    • 8.6.5.1. Key country dynamic
    • 8.6.5.2. South Korea estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.6.5.3. Regulatory framework
    • 8.6.5.4. Reimbursement scenario
    • 8.6.5.5. Competitive insights
    • 8.6.5.6. South Korea audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. Australia
    • 8.6.6.1. Key country dynamic
    • 8.6.6.2. Australia estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.6.6.3. Regulatory framework
    • 8.6.6.4. Reimbursement scenario
    • 8.6.6.5. Competitive insights
    • 8.6.6.6. Australia audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key country dynamic
    • 8.6.7.2. Thailand estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.6.7.3. Regulatory framework
    • 8.6.7.4. Reimbursement scenario
    • 8.6.7.5. Competitive insights
    • 8.6.7.6. Thailand audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key country dynamic
    • 8.7.2.2. Brazil estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. Competitive insights
    • 8.7.2.6. Brazil audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key country dynamic
    • 8.7.3.2. Argentina estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.7.3.3. Regulatory framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. Competitive insights
    • 8.7.3.6. Argentina audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. MEA audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key country dynamic
    • 8.8.2.2. Regulatory framework
    • 8.8.2.3. Reimbursement scenario
    • 8.8.2.4. Competitive insights
    • 8.8.2.5. South Africa audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key country dynamic
    • 8.8.3.2. Saudi Arabia estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.8.3.3. Regulatory framework
    • 8.8.3.4. Reimbursement scenario
    • 8.8.3.5. Competitive insights
    • 8.8.3.6. Saudi Arabia audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key country dynamic
    • 8.8.4.2. UAE estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.8.4.3. Regulatory framework
    • 8.8.4.4. Reimbursement scenario
    • 8.8.4.5. Competitive insights
    • 8.8.4.6. UAE audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key country dynamic
    • 8.8.5.2. Kuwait estimated prevalence of age-related & other hearing loss, 2018 - 2030 (Million)
    • 8.8.5.3. Reimbursement scenario
    • 8.8.5.4. Competitive insights
    • 8.8.5.5. Kuwait audiology devices market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Participant Overview
• 9.2. Company Market Position Analysis
• 9.3. Company Categorization
• 9.4. Strategy Mapping
• 9.5. Company Profiles/Listing
  • 9.5.1. Demant A/S
    • 9.5.1.1. Overview
    • 9.5.1.2. Financial performance
    • 9.5.1.3. Product benchmarking
    • 9.5.1.4. Strategic initiatives
  • 9.5.2. GN Store Nord A/S
    • 9.5.2.1. Overview
    • 9.5.2.2. Financial performance
    • 9.5.2.3. Product benchmarking
    • 9.5.2.4. Strategic initiatives
  • 9.5.3. Sonova
    • 9.5.3.1. Overview
    • 9.5.3.2. Financial performance
    • 9.5.3.3. Product benchmarking
    • 9.5.3.4. Strategic initiatives
  • 9.5.4. Starkey Laboratories, Inc.
    • 9.5.4.1. Overview
    • 9.5.4.2. Financial performance
    • 9.5.4.3. Product benchmarking
    • 9.5.4.4. Strategic initiatives
  • 9.5.5. MED-EL Medical Electronics
    • 9.5.5.1. Overview
    • 9.5.5.2. Financial performance
    • 9.5.5.3. Product benchmarking
    • 9.5.5.4. Strategic initiatives
  • 9.5.6. Cochlear Ltd.
    • 9.5.6.1. Overview
    • 9.5.6.2. Financial performance
    • 9.5.6.3. Product benchmarking
    • 9.5.6.4. Strategic initiatives
  • 9.5.7. WS Audiology A/S
    • 9.5.7.1. Overview
    • 9.5.7.2. Financial performance
    • 9.5.7.3. Product benchmarking
    • 9.5.7.4. Strategic initiatives
  • 9.5.8. MAICO Diagnostics GmbH
    • 9.5.8.1. Overview
    • 9.5.8.2. Financial performance
    • 9.5.8.3. Product benchmarking
    • 9.5.8.4. Strategic initiatives
  • 9.5.9. Oticon Medical
    • 9.5.9.1. Overview
    • 9.5.9.2. Financial performance
    • 9.5.9.3. Product benchmarking
    • 9.5.9.4. Strategic initiatives
  • 9.5.10. INVENTIS srl
    • 9.5.10.1. Overview
    • 9.5.10.2. Financial performance
    • 9.5.10.3. Product benchmarking
    • 9.5.10.4. Strategic initiatives
  • 9.5.11. Tech Innovations and M&A trends
    • 9.5.11.1. Overview
    • 9.5.11.2. Financial performance
    • 9.5.11.3. Product benchmarking
    • 9.5.11.4. Strategic initiatives